⌘K

Login Start Free

Home/Filings/4/0001000229-19-000043

4//SEC Filing

Dunlap Charles L 4

Accession 0001000229-19-000043

CIK 0001000229other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:02 PM ET

Size

12.7 KB

Accession

0001000229-19-000043

Insider Transaction Report

Form 4

Period: 2019-04-01

CORE LABORATORIES N VCLB

Dunlap Charles L

Director

Transactions

Exercise/Conversion
Common Shares
2019-04-01+1,387→ 8,069 total
Exercise/Conversion
Common Shares
2019-04-01+1,335→ 6,689 total
Tax Payment
Common Shares
2019-04-01$68.93/sh−7$483→ 8,062 total
Exercise/Conversion
Restricted Shares
2019-04-01−1,335→ 0 total
Exercise: $0.00→ Common Shares (1,335 underlying)
Tax Payment
Common Shares
2019-04-01$68.93/sh−7$483→ 6,682 total
Exercise/Conversion
Restricted Shares
2019-04-01−1,387→ 0 total
Exercise: $0.00→ Common Shares (1,387 underlying)

Footnotes (2)

[F1]The Restricted Shares vested at the end of a three-year vesting period ending April 1, 2019.
[F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2019.

Documents

1 file

4
wf-form4_155423535071698.xmlPrimary
FORM 4

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1

filerCIK 0001437468

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 4:02 PM ET
Size: 12.7 KB

View on SEC.gov